These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15123400)

  • 1. Prostate cancer and coronary heart disease: correlation or coincidence?
    Moyad MA; Sonnleithner M
    Urol Clin North Am; 2004 May; 31(2):207-12. PubMed ID: 15123400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving overall men's health and potentially reducing the risk of certain cancers via serum markers and risk assessment for coronary heart disease.
    Moyad MA
    Urol Oncol; 2004; 22(6):485-9. PubMed ID: 15610866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of cardiovascular mortality in prostate cancer patients in the Rotterdam randomized screening trial.
    Otto SJ; Schröder FH; de Koning HJ
    J Clin Oncol; 2006 Sep; 24(25):4184-9. PubMed ID: 16943535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lifestyle recommendations to prevent prostate cancer, part II: time to redirect our attention?
    Moyad MA; Carroll PR
    Urol Clin North Am; 2004 May; 31(2):301-11. PubMed ID: 15123409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding treatments for bone loss and bone metastases in patients with prostate cancer: a practical review and guide for the clinician.
    Higano CS
    Urol Clin North Am; 2004 May; 31(2):331-52. PubMed ID: 15123412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating localized prostate cancer and identifying candidates for focal therapy.
    Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
    Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of dyslipidemia and general ineffectiveness of its treatment in both primary and secondary prevention of coronary heart disease within family medicine framework--results of LIPIDOGRAM 2005--a nationwide epidemiological study. Dyslipidemia in Poland--ineffective treatment.
    Konduracka E; Jóźwiak J; Mastej M; Lukas W; Tykarski A; Szczepaniak-Chicheł L; Piwowarska W
    Przegl Lek; 2008; 65(12):834-7. PubMed ID: 19441674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin drugs and risk of advanced prostate cancer.
    Platz EA; Leitzmann MF; Visvanathan K; Rimm EB; Stampfer MJ; Willett WC; Giovannucci E
    J Natl Cancer Inst; 2006 Dec; 98(24):1819-25. PubMed ID: 17179483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of cardiovascular disease risk factors in patients from Croatian Zagorje County treated at Department of Medicine, Zabok General Hospital from 2000 to 2006.
    Pesek K; Pesek T; Rados M; Buković D; Fures R; Cuk V
    Coll Antropol; 2007 Sep; 31(3):709-15. PubMed ID: 18041378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of major modifiable risk factors among patients with coronary artery disease--a retrospective analysis.
    Achari V; Thakur AK
    J Assoc Physicians India; 2004 Feb; 52():103-8. PubMed ID: 15656042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for prostate cancer: updated experience from the Tyrol study.
    Horninger W; Berger A; Pelzer A; Klocker H; Oberaigner W; Schönitzer D; Severi G; Robertson C; Boyle P; Bartsch G
    Can J Urol; 2005 Feb; 12 Suppl 1():7-13; discussion 92-3. PubMed ID: 15780158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of serum markers for prostate cancer.
    Stenman UH; Abrahamsson PA; Aus G; Lilja H; Bangma C; Hamdy FC; Boccon-Gibod L; Ekman P
    Scand J Urol Nephrol Suppl; 2005 May; (216):64-81. PubMed ID: 16019759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atheromatous disease and latent prostate cancer. A correlation or a coincidence.
    Stamatiou KN; Alevizos AG; Natzar MA; Karakoukis NG; Mariolis AD; Sofras FA
    Saudi Med J; 2006 May; 27(5):746-7. PubMed ID: 16680281
    [No Abstract]   [Full Text] [Related]  

  • 15. Minority issues in prostate disease.
    French DB; Jones LA
    Med Clin North Am; 2005 Jul; 89(4):805-16. PubMed ID: 15925651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of subclinical coronary atherosclerosis and National Cholesterol Education Panel guidelines in asymptomatic Brazilian men.
    Nasir K; Santos RD; Roguin A; Carvalho JA; Meneghello R; Blumenthal RS
    Int J Cardiol; 2006 Mar; 108(1):68-75. PubMed ID: 16516700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective review of sex differences in the management of dyslipidemia in coronary heart disease: an analysis of patient data from a Maryland-based health maintenance organization.
    Cooke CE; Hammerash WJ
    Clin Ther; 2006 Apr; 28(4):591-9. PubMed ID: 16750470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary causes of death after permanent prostate brachytherapy.
    Bittner N; Merrick GS; Galbreath RW; Butler WM; Wallner KE; Allen ZA; Brammer SG; Moyad M
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):433-40. PubMed ID: 18448268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancers of the prostate, penis, and testicles: epidemiology, prevention, and treatment.
    Stotts RC
    Nurs Clin North Am; 2004 Jun; 39(2):327-40. PubMed ID: 15159183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why a statin and/or another proven heart healthy agent should be utilized in the next major cancer chemoprevention trial: part II.
    Moyad MA
    Urol Oncol; 2004; 22(6):472-7. PubMed ID: 15610864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.